SELECTED ABSTRACTS FOR POSTER PRESENTATIONS
IN ALPHABETIC ORDER ACCORDING TO THE NAME OF THE FIRST AUTHOR
CLINICAL POSTERS
Poster 3: HYPOGRANULAR VARIANT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH
KMT2A-SEPT6 FUSION GENE WITHOUT RARA GENE REARRANGEMENT: A
CASE REPORT
Aleksandra Borkovskaya, Svetlana Lebedeva, Olga Soldatkina, Maria Dubrovina,
Aleksandr Popov, Michael Maschan, Aleksey Maschan, Galina Novichkova, Elena
Zerkalenkova and Yulia Olshanskaya
Poster 4: DARATUMUMAB EFFICACY IN RELAPSED T-ACUTE LYMPHOBLASTIC
LEUKEMIA (T-ALL): TWO CLINICAL CASES
Marco Cerrano, Barbara Castella, Giuseppe Lia, Lucia Brunello, Sara Butera, Matilde
Scaldaferri, Massimo Massaia, Mario Boccadoro, Dario Ferrero, Benedetto Bruno and
Luisa Giaccone
Poster 5: GENETIC CHARACTERIZATION AND OUTCOME ANALYSIS IN NON-M3
PAEDIATRIC AML: REAL WORLD DATA
Maria Couto, Tereza Oliva, Marta Almeida, Vitor Costa, Filipa Almeida, Catia Sousa,
Catarina Sousa, Silvia Silva, Susana Bizarro, Susana Lisboa, Lurdes Torres, Cecília
Correia, Teresa Sousa, Manuel Teixeira, Carlos Mendes, Armando Pinto and Ana Maia
Ferreira
Poster 6: PH+ ALL RELAPSE IN THE CNS WITH THE T315I MUTATION
Maria Eduarda Couto, Isabel Oliveira and José Mariz
Poster 7: DISSEMINATED INTRAVASCULAR COAGULATION AS A PRESENTING FEATURE
OF ACUTE LYMPHOBLASTIC LEUKAEMIA WITH T(1;19); TCF-PBX1: AN
UNUSUAL MANIFESTATION WITH TREATMENT IMPLICATIONS.
Pedro de Vasconcelos M, Guilherme Sapinho, Graça Esteves, João Lacerda and João
Raposo
Poster 8: A RARE CASE OF SIMULTANEOUS PRESENTATION OF MULTIPLE MYELOMA
AND ACUTE MYELOID LEUKAEMIA: A CASE REPORT
Ines dos Santos Marques, Rui Bergantim, Eliana Aguiar and Fernanda Trigo
Poster 9: ACUTE LEUKAEMIA IN PREGNANCY AND PUERPERIUM
Ines dos Santos Marques, Carolina Marini, Eliana Aguiar, Rui Bergantim and Fernanda
Trigo
Poster 10: CD19 NEGATIVE CLONE EMERGENCE AFTER TREATMENT WITH ANTI-CD22
ANTIBODY-DRUG CONJUGATE IN A PHILADELPHIA POSITIVE ACUTE
LYMPHOBLASTIC LEUKEMIA PATIENT
V. Douka, A. Papalexandri, A. Marvaki, T. Chatzikonstantinou, M. Iskas, R. Avramidou,
V. Tachynopoulou, A. Tsompanakou and A. Anagnostopoulos
SCIENTIFIC
PROGRAMME
RARE SUBSETS OF
ACUTE LEUKAEMIA
TRACKING LEUKAEMIC
STEM CELLS (LSCs)
ROUTINE DIAGNOSIS
GENE EXPRESSION
AND MUTATIONAL
PROFILING
DEBATE 1 – ALL
PATIENTS WITH
INTERMEDIATE-RISK
AML MUST BE
TRANSPLANTED
INTERACTIVE
CASES 1 – MUTATION-BASED
THERAPY
OFF-LABEL
ROUNDTABLE –
SHOULD WE REALLY
USE NEW TARGETED
INHIBITORS AS SINGLE
AGENTS ?
ADDITION OF A 3RD
AGENT TO FRONTLINE
7+3
ROUNDTABLE –
CURATIVE OPTIONS
FOR OLDER AML
INTERACTIVE CASES 2
DEBATE 2 - BEST
TREATMENT FOR
NPM1-MUTATED AML IN
THE NEXT FUTURE ?
ALLOGENEIC
HAEMATOPOIETIC
STEM CELL
TRANSPLANTATION
(HSCT)
IMMUNOTHERAPY FOR
ACUTE LEUKAEMIA
DEBATE 3 - T-ALL:
WHERE ARE WE GOING
NOW?
SELECTED ABSTRACTS
AND CLINICAL
CASES FOR AN ORAL
PRESENTATION
SELECTED ABSTRACTS
FOR A POSTER
PRESENTATION
DISCLOSURES